Economy
Agreement Inked To Establish Vaccines Factory In Khazaen City Worth RO20M

Khazaen Economic City signed an agreement with Opal For Biopharmaceuticals and Business Company to establish a factory for the production of biological human vaccines to the tune of RO20mn.
The first phase of the project will be set up on a total area of 37,000 square meters.
The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal For Biopharmaceuticals and Business Company.
Al Thuhli said that this project will be the first vaccines factory in Khazaen Economic City and it targets local and international markets. The agreement, Al Thuhli added, comes as part of Khazaen’s efforts in attracting local and international investments.
-
Economy2 months ago
Is Gold a Good Investment in 2025? A Deep Dive into the Precious Metal’s Future
-
Alamaliktistaad Magazines2 months ago
Al-Iktisaad, March 2025
-
OER Magazines2 months ago
OER, March 2025
-
News2 months ago
Nothing Phone 3a and 3a Pro launches in the Middle East
-
Automotive1 month ago
South Korea Plans to Support Auto Sector with US$2B Following US Tariffs
-
News1 month ago
Oman Oil Prices Witness Drop Amid Shifting Global Trade Dynamics
-
News1 month ago
Aligning HR Strategies with Oman Vision 2040: A Roadmap for Organisational Growth – OER Business Summit 2025
-
News2 months ago
Omantel Partners with TeKnowledge to Enhance Employee Skills in AI & Data Science